Literature DB >> 18559509

Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.

Ling Wang1, Blossom Damania.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three different human malignancies, including Kaposi's sarcoma (KS), primary effusion lymphoma, and multicentric Castleman's disease. The KS lesion is of endothelial cell in origin and is highly dependent on autocrine and paracrine factors for survival and growth. In this study, we show that KSHV infection of endothelial cells induces the activation of the prosurvival phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin pathway. KSHV infection of endothelial cells augmented cell survival in the presence of apoptotic inducers, including etoposide and staurosporine, and under conditions of serum deprivation. We found that KSHV infection of endothelial cells also increased the ability of these cells to form an in vitro tubular network under conditions of stress and growth factor deprivation. Finally, we show that the nuclear factor-kappaB and PI3K pathways are also required for endothelial tubular network formation. Collectively, these results suggest that KSHV infection of endothelial cells modulates cell signaling pathways and induces cell survival and angiogenesis, thereby contributing to the pathogenesis induced by KSHV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559509      PMCID: PMC2612117          DOI: 10.1158/0008-5472.CAN-07-5988

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

Review 1.  Protein kinases as mediators of phosphoinositide 3-kinase signaling.

Authors:  A Toker
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

2.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Bartonella-associated endothelial proliferation depends on inhibition of apoptosis.

Authors:  James E Kirby; Dawn M Nekorchuk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas.

Authors:  Y Aoki; G Tosato
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

5.  Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.

Authors:  Madhuri Ramanathan; Grace Pinhal-Enfield; Irene Hao; Samuel Joseph Leibovich
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

6.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

7.  Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.

Authors:  R Binétruy-Tournaire; C Demangel; B Malavaud; R Vassy; S Rouyre; M Kraemer; J Plouët; C Derbin; G Perret; J C Mazié
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

8.  DAPP1 undergoes a PI 3-kinase-dependent cycle of plasma-membrane recruitment and endocytosis upon cell stimulation.

Authors:  K E Anderson; P Lipp; M Bootman; S H Ridley; J Coadwell; L Rönnstrand; J Lennartsson; A B Holmes; G F Painter; J Thuring; Z Lim; H Erdjument-Bromage; A Grewal; P Tempst; L R Stephens; P T Hawkins
Journal:  Curr Biol       Date:  2000-11-16       Impact factor: 10.834

9.  Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

Authors:  B T Navé; M Ouwens; D J Withers; D R Alessi; P R Shepherd
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

10.  Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.

Authors:  M Tewari; L T Quan; K O'Rourke; S Desnoyers; Z Zeng; D R Beidler; G G Poirier; G S Salvesen; V M Dixit
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

View more
  78 in total

1.  Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2.

Authors:  Meilan He; Wei Zhang; Thomas Bakken; Melissa Schutten; Zsolt Toth; Jae U Jung; Parkash Gill; Mark Cannon; Shou-Jiang Gao
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

2.  Development of novel adenosine monophosphate-activated protein kinase activators.

Authors:  Jih-Hwa Guh; Wei-Ling Chang; Jian Yang; Su-Lin Lee; Shuo Wei; Dasheng Wang; Samuel K Kulp; Ching-Shih Chen
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

Review 3.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 4.  Viruses and autophagy.

Authors:  Sagar B Kudchodkar; Beth Levine
Journal:  Rev Med Virol       Date:  2009-11       Impact factor: 6.989

5.  Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

Authors:  Aadra P Bhatt; Prasanna M Bhende; Sang-Hoon Sin; Debasmita Roy; Dirk P Dittmer; Blossom Damania
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

6.  Latent KSHV infection increases the vascular permeability of human endothelial cells.

Authors:  Christophe Guilluy; Zhigang Zhang; Prasanna M Bhende; Lisa Sharek; Ling Wang; Keith Burridge; Blossom Damania
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

7.  KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction.

Authors:  Lu Dai; Momka Bratoeva; Bryan P Toole; Zhiqiang Qin; Chris Parsons
Journal:  Int J Cancer       Date:  2011-10-24       Impact factor: 7.396

8.  mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis.

Authors:  Debasmita Roy; Sang-Hoon Sin; Amy Lucas; Raman Venkataramanan; Ling Wang; Anthony Eason; Veenadhari Chavakula; Isaac B Hilton; Kristen M Tamburro; Blossom Damania; Dirk P Dittmer
Journal:  Cancer Res       Date:  2013-02-04       Impact factor: 12.701

9.  Kaposi sarcoma-associated herpesvirus g protein-coupled receptor enhances endothelial cell survival in part by upregulation of bcl-2.

Authors:  Elizabeth R Abboud; Bryan D Shelby; Magdalena Angelova; Anne B Nelson; Marybeth Ferris; Harris E McFerrin; Cindy A Morris; Deborah E Sullivan
Journal:  Ochsner J       Date:  2013

10.  Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.

Authors:  Andrea J O'Hara; Pauline Chugh; Ling Wang; Eduardo M Netto; Estrella Luz; William J Harrington; Bruce J Dezube; Blossom Damania; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.